J Cancer 2015; 6(12):1255-1259. doi:10.7150/jca.12969
CT120A Acts as an Oncogene in Head and Neck Squamous Cell Carcinoma
1. Cerrahpasa Medical Faculty, Department of Medical Biology, Istanbul University, Istanbul, Turkey
2. Cerrahpasa Medical Faculty, Department of Otorhinolaryngology, Istanbul University, Istanbul, Turkey
Baltaci E, Ekizoglu S, Sari E, Karaman E, Ulutin T, Buyru N. CT120A Acts as an Oncogene in Head and Neck Squamous Cell Carcinoma. J Cancer 2015; 6(12):1255-1259. doi:10.7150/jca.12969. Available from http://www.jcancer.org/v06p1255.htm
Squamous cell carcinoma of the head and neck (HNSCC) is among the most frequent cancers worldwide. The etiology and pathogenesis of HNSCC are influenced by multiple genetic factors in addition to environmental and lifestyle-related factors. However, the mechanism underlying the HNSCC is still far from clear.
The membrane associated gene CT120 was previously identified from chromosome 17p13.3 as a lung cancer-associated gene. Its function as an activator of the Erk and Akt signaling pathways in human lung cancer cell lines suggested that CT120 has an oncogenic function. However, there is no data in the literature on the role of CT120 in any other cancer type. Therefore, the aim of this study was to determine the expression rate and probable function of CT120 in HNSCC.
Tumor tissues from 50 patients were analyzed by real-time quantitative RT-PCR to investigate the expression rate and by direct sequencing to differentiate the CT120A and CT120B variants. CT120 overexpression was observed in 58% of tumors compared to non-cancerous tissue samples and this up-regulation was directly associated with the upregulation of the CT120A variant and with the stage of the disease (p=0.001).
Our results indicate that the CT120 gene may function in the development of HNSCC.
Keywords: HNSCC, CT120, Variant, Expression